These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8099956)
1. Studies on an oral iron chelator: 1,2-dimethyl-3-hydroxy-pyrid-4-one (DMHP). Mechanism of intestinal absorption in rabbits. Railkar AM; Awni WM; Camp RJ; Rahman YE J Pharm Pharmacol; 1993 May; 45(5):400-5. PubMed ID: 8099956 [TBL] [Abstract][Full Text] [Related]
2. Studies of an oral iron chelator: 1,2-dimethyl-3-hydroxy-pyrid-4-one. I. Iron excretion in rats: development of a new rapid microwave method for iron analysis in faeces. Venkataram S; Rahman YE Br J Haematol; 1990 Jun; 75(2):274-7. PubMed ID: 2372514 [TBL] [Abstract][Full Text] [Related]
3. Crystal structures of a new oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its solvates with acetic acid and formic acid. Chan HK; Ghosh S; Venkataram S; Rahman YE; Grant DJ J Pharm Sci; 1992 Apr; 81(4):353-8. PubMed ID: 1501073 [TBL] [Abstract][Full Text] [Related]
4. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells. Link G; Pinson A; Hershko C Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral iron chelator L1 on iron absorption in man. Dresow B; Fischer R; Nielsen P; Gabbe EE; Piga A Ann N Y Acad Sci; 1998 Jun; 850():466-8. PubMed ID: 9668586 [No Abstract] [Full Text] [Related]
6. Pharmaceutical analysis of the oral iron chelator deferiprone (DMHP,L1). Lange R; Lameijer W; Slijkhuis C; de Kaste D Pharm World Sci; 1996 Aug; 18(4):142-7. PubMed ID: 8873230 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic disposition of the oral iron chelator deferiprone in the domestic pigeon (Columba livia). Whiteside DP; Barker IK; Conlon PD; Tesoro A; Thiessen JJ; Mehren KG; Jacobs RM; Spino M J Avian Med Surg; 2007 Jun; 21(2):121-9. PubMed ID: 18065133 [TBL] [Abstract][Full Text] [Related]
8. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic disposition of the oral iron chelator deferiprone in the white leghorn chicken. Whiteside DP; Barker IK; Conlon PD; Tesoro A; Thiessen JJ; Mehren KG; Jacobs RM; Spino M J Avian Med Surg; 2007 Jun; 21(2):110-20. PubMed ID: 18065132 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Thuma PE; Olivieri NF; Mabeza GF; Biemba G; Parry D; Zulu S; Fassos FF; McClelland RA; Koren G; Brittenham GM; Gordeuk VR Am J Trop Med Hyg; 1998 Mar; 58(3):358-64. PubMed ID: 9546419 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with thalassemia. Matsui D; Klein J; Hermann C; Grunau V; McClelland R; Chung D; St-Louis P; Olivieri N; Koren G Clin Pharmacol Ther; 1991 Sep; 50(3):294-8. PubMed ID: 1914364 [TBL] [Abstract][Full Text] [Related]
13. Effect of bile salts on amino acid transport by rabbit intestine. Hajjar JJ; Khuri RN; Bikhazi AB Am J Physiol; 1975 Aug; 229(2):518-23. PubMed ID: 1163679 [TBL] [Abstract][Full Text] [Related]
14. Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Kontoghiorghes GJ; Hoffbrand AV Br J Haematol; 1986 Apr; 62(4):607-13. PubMed ID: 3964556 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levels. Fassos FF; Klein J; Fernandes D; Matsui D; Olivieri NF; Koren G Int J Clin Pharmacol Ther; 1996 Jul; 34(7):288-92. PubMed ID: 8832304 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Kontoghiorghes GJ; Goddard JG; Bartlett AN; Sheppard L Clin Pharmacol Ther; 1990 Sep; 48(3):255-61. PubMed ID: 2401124 [TBL] [Abstract][Full Text] [Related]
17. Microencapsulation of an iron chelator for sustained release and crystal habit modification. Venkataram S; Khohlokwane M J Microencapsul; 1996; 13(5):519-25. PubMed ID: 8864989 [TBL] [Abstract][Full Text] [Related]
18. 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Kontoghiorghes GJ; Aldouri MA; Sheppard L; Hoffbrand AV Lancet; 1987 Jun; 1(8545):1294-5. PubMed ID: 2884415 [TBL] [Abstract][Full Text] [Related]
19. The influence of lactation on L-proline absorption from small intestine in the albino rat. Datta U; Sharma RK Indian J Physiol Pharmacol; 1985; 29(1):27-32. PubMed ID: 4055015 [TBL] [Abstract][Full Text] [Related]
20. Zinc intestinal absorption in rats: specificity of amino acids as ligands. Wapnir RA; Stiel L J Nutr; 1986 Nov; 116(11):2171-9. PubMed ID: 3794825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]